Your browser doesn't support javascript.
loading
Phase-change materials-based platforms for biomedicine.
Chen, Biao-Qi; Pan, Yu-Jing; Zhang, Da-Gui; Xia, Hong-Ying; Kankala, Ranjith Kumar.
Afiliação
  • Chen BQ; Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, China.
  • Pan YJ; Fujian Provincial Key Laboratory of Biochemical Technology (Huaqiao University), Xiamen, China.
  • Zhang DG; Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, China.
  • Xia HY; Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, China.
  • Kankala RK; Institute of Biomaterials and Tissue Engineering, Huaqiao University, Xiamen, China.
Front Bioeng Biotechnol ; 10: 989953, 2022.
Article em En | MEDLINE | ID: mdl-36118587
ABSTRACT
Recently, phase-change materials (PCMs) have gathered enormous attention in diverse fields of medicine, particularly in bioimaging, therapeutic delivery, and tissue engineering. Due to the excellent physicochemical characteristics and morphological characteristics of PCMs, several developments have been demonstrated in the construction of diverse PCMs-based architectures toward providing new burgeoning opportunities in developing innovative technologies and improving the therapeutic benefits of the existing formulations. However, the fabrication of PCM-based materials into colloidally stable particles remains challenging due to their natural hydrophobicity and high crystallinity. This review systematically emphasizes various PCMs-based platforms, such as traditional PCMs (liposomes) and their nanoarchitectured composites, including PCMs as core, shell, and gatekeeper, highlighting the pros and cons of these architectures for delivering bioactives, imaging anatomical features, and engineering tissues. Finally, we summarize the article with an exciting outlook, discussing the current challenges and future prospects for PCM-based platforms as biomaterials.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China